HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.

Abstract
Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are at risk of developing benign (neurofibromas) and malignant peripheral nerve sheath tumors (MPNST). The AXL receptor tyrosine kinase has been implicated in several kinds of cancers, but so far no studies have investigated the role of AXL in NF1 related tumorigenesis. Recently, the soluble fraction from the extracellular domain of AXL (sAXL) has been found in human plasma, and its level was correlated to poor prognosis in patients with renal cancer. Compared to normal human Schwann cells, a significantly high expression level of AXL was found in three of the four MPNST cell lines and two of the three primary MPNST tissues. Similarly, the level of sAXL in conditioned media corresponded to the protein and mRNA levels of AXL in the MPNST cell lines. Furthermore, in two different human MPNST xenograft models, the human sAXL could be detected in the mouse plasma. Its level was proportionate to the size of the xenograft tumors, while no human sAXL was detect prior to the formation of the tumors. Treatment with a newly developed photodynamic therapy, prevented further tumor growth and resulted in drastically reduced the levels of sAXL compared to that of the control group. Finally, the level of sAXL was significantly increased in patients with plexiform tumors compared to patients with only dermal neurofibromas, further supporting the role of sAXL as a marker for NF1 related tumor burden.
AuthorsGunnar Johansson, Po-Chun Peng, Po-Yuan Huang, Hsiung-Fei Chien, Kuo-Tai Hua, Min-Liang Kuo, Chin-Tin Chen, Ming-Jen Lee
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e115916 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25551830 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Proto-Oncogene Proteins
  • Receptor Protein-Tyrosine Kinases
  • Axl Receptor Tyrosine Kinase
Topics
  • Adult
  • Animals
  • Biomarkers, Tumor (blood, metabolism)
  • Cell Line, Tumor
  • Female
  • Humans
  • Male
  • Mice
  • Middle Aged
  • Neoplasm Transplantation
  • Neurilemmoma (pathology)
  • Neurofibroma, Plexiform (blood)
  • Neurofibromatosis 1 (blood, mortality, therapy)
  • Phosphorylation
  • Photochemotherapy
  • Prognosis
  • Proto-Oncogene Proteins (blood, metabolism)
  • Receptor Protein-Tyrosine Kinases (blood, metabolism)
  • Schwann Cells (metabolism)
  • Transplantation, Heterologous
  • Tumor Burden
  • Axl Receptor Tyrosine Kinase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: